Clinical PET/MR Imaging in Dementia and Neuro-Oncology

Forskning

Clinical PET/MR Imaging in Dementia and Neuro-Oncology

Research output: Contribution to journal › Review › Research › peer-review

Standard

Clinical PET/MR Imaging in Dementia and Neuro-Oncology. / Henriksen, Otto M.; Marner, Lisbeth; Law, Ian.

In: PET Clinics, Vol. 11, No. 4, 10.2016, p. 441-52.

Research output: Contribution to journal › Review › Research › peer-review

Harvard

Henriksen, OM, Marner, L & Law, I 2016, 'Clinical PET/MR Imaging in Dementia and Neuro-Oncology', PET Clinics, vol. 11, no. 4, pp. 441-52. https://doi.org/10.1016/j.cpet.2016.05.003

APA

Henriksen, O. M., Marner, L., & Law, I. (2016). Clinical PET/MR Imaging in Dementia and Neuro-Oncology. PET Clinics, 11(4), 441-52. https://doi.org/10.1016/j.cpet.2016.05.003

Vancouver

Henriksen OM, Marner L, Law I. Clinical PET/MR Imaging in Dementia and Neuro-Oncology. PET Clinics. 2016 Oct;11(4):441-52. https://doi.org/10.1016/j.cpet.2016.05.003

Author

Henriksen, Otto M. ; Marner, Lisbeth ; Law, Ian. / Clinical PET/MR Imaging in Dementia and Neuro-Oncology. In: PET Clinics. 2016 ; Vol. 11, No. 4. pp. 441-52.

Bibtex

@article{49932d58a1634d72828f11e5867abd6f,

title = "Clinical PET/MR Imaging in Dementia and Neuro-Oncology",

abstract = "The introduction of hybrid PET/MRI systems allows simultaneous multimodality image acquisition of high technical quality. This technique is well suited for the brain, and particularly in dementia and neuro-oncology. In routine use combinations of well-established MRI sequences and PET tracers provide the most optimal and clinically valuable protocols. For dementia the [18F]-fluorodeoxyglucose (FDG) has merit with a simultaneous four sequence MRI protocol of 20 min supported by supplementary statistical reading tools and quantitative measurements of the hippocampal volume. Clinical PET/MRI using [18F]-fluoro-ethyl-tyrosine (FET) also abide to the expectations of the adaptive and versatile diagnostic tool necessary in neuro-oncology covering both simple 20 min protocols for routine treatment surveillance and complicated 90 min brain and spinal cord protocols in pediatric neuro-oncology under general anesthesia. The clinical value of adding advanced MRI sequences in multiparametric imaging setting, however, is still undocumented.",

keywords = "Brain, Brain Mapping, Brain Neoplasms, Dementia, Humans, Magnetic Resonance Imaging, Multimodal Imaging, Positron-Emission Tomography, Journal Article, Review",

author = "Henriksen, {Otto M.} and Lisbeth Marner and Ian Law",

year = "2016",

month = oct,

doi = "10.1016/j.cpet.2016.05.003",

language = "English",

volume = "11",

pages = "441--52",

journal = "P E T Clinics",

issn = "1556-8598",

publisher = "W.B.Saunders Co.",

number = "4",

}

RIS

TY - JOUR

T1 - Clinical PET/MR Imaging in Dementia and Neuro-Oncology

AU - Henriksen, Otto M.

AU - Marner, Lisbeth

AU - Law, Ian

PY - 2016/10

Y1 - 2016/10

N2 - The introduction of hybrid PET/MRI systems allows simultaneous multimodality image acquisition of high technical quality. This technique is well suited for the brain, and particularly in dementia and neuro-oncology. In routine use combinations of well-established MRI sequences and PET tracers provide the most optimal and clinically valuable protocols. For dementia the [18F]-fluorodeoxyglucose (FDG) has merit with a simultaneous four sequence MRI protocol of 20 min supported by supplementary statistical reading tools and quantitative measurements of the hippocampal volume. Clinical PET/MRI using [18F]-fluoro-ethyl-tyrosine (FET) also abide to the expectations of the adaptive and versatile diagnostic tool necessary in neuro-oncology covering both simple 20 min protocols for routine treatment surveillance and complicated 90 min brain and spinal cord protocols in pediatric neuro-oncology under general anesthesia. The clinical value of adding advanced MRI sequences in multiparametric imaging setting, however, is still undocumented.

AB - The introduction of hybrid PET/MRI systems allows simultaneous multimodality image acquisition of high technical quality. This technique is well suited for the brain, and particularly in dementia and neuro-oncology. In routine use combinations of well-established MRI sequences and PET tracers provide the most optimal and clinically valuable protocols. For dementia the [18F]-fluorodeoxyglucose (FDG) has merit with a simultaneous four sequence MRI protocol of 20 min supported by supplementary statistical reading tools and quantitative measurements of the hippocampal volume. Clinical PET/MRI using [18F]-fluoro-ethyl-tyrosine (FET) also abide to the expectations of the adaptive and versatile diagnostic tool necessary in neuro-oncology covering both simple 20 min protocols for routine treatment surveillance and complicated 90 min brain and spinal cord protocols in pediatric neuro-oncology under general anesthesia. The clinical value of adding advanced MRI sequences in multiparametric imaging setting, however, is still undocumented.

KW - Brain

KW - Brain Mapping

KW - Brain Neoplasms

KW - Dementia

KW - Humans

KW - Magnetic Resonance Imaging

KW - Multimodal Imaging

KW - Positron-Emission Tomography

KW - Journal Article

KW - Review

U2 - 10.1016/j.cpet.2016.05.003

DO - 10.1016/j.cpet.2016.05.003

M3 - Review

C2 - 27593248

VL - 11

SP - 441

EP - 452

JO - P E T Clinics

JF - P E T Clinics

SN - 1556-8598

IS - 4

ER -

ID: 179311788